Neuroscience News

Scientists in the lab of chemical engineer Monther Abu-Remaileh are uncovering the cellular functions that go awry in degenerative brain disorders and identifying therapies that could treat them.

In which anesthesiologist Martin Angst shares how studying the biology of recovery may reveal why some aging brains withstand stress while others quietly unravel.

A team at Stanford, supported by the Knight Initiative for Brain Resilience, is using the biology of recovery to uncover why some aging brains withstand stress while others quietly unravel.

In a favorite 2024 episode, we spoke with Jaimie Henderson, a Stanford neurosurgeon leading groundbreaking research in brain-machine interfaces.

In which Anthony Wagner and Beth Mormino share what they are learning from the Stanford Aging and Memory Study about the nature of healthy brain aging.

Stanford bioengineer Stanley Qi is developing advanced gene-editing tools to treat life-threatening diseases and slow the onset of neurological aging.

Cancer treatment with a cell-based immunotherapy causes mild cognitive impairment, according to research by Wu Tsai Neuro affiliate Michelle Monje and colleagues. They also identified compounds that could treat it.

A new analysis of a vaccination program in Wales by a Knight Initiative–supported team found that the shingles vaccine appeared to lower new dementia diagnos

Knight Initiative–supported research by Pascal Geldsetzer and colleagues adds to evidence that preventing the viral infection can help stave off cognitive de

Psychiatrist Anna Lembke shares what scientists have discovered so far about the potential for GLP-1s in addiction treatment.

Young adults crave closeness, says Stanford psychologist Jamil Zaki, but often misjudge how much their peers want that, too.

Our brains and digestive tracts are in constant communication.

This week on the podcast, Stanford psychiatry professor Erin Gibson joins us again to share the latest findings on sleep, myelin, and neurodegenerative disease.

Stanford researchers have created a compound that relieves multiple types of pain in mice without building tolerance or causing psychoactive side effects.

Stanford Medicine spoke with neurologist Helen Bronte-Stewart, who conducted research that led to the development of a technology recently approved by the U.

Associate professor Jason Yeatman discusses the adoption of the Stanford-developed Rapid Online Assessment of Reading (ROAR) as a state-approved dyslexia scr